Submitted by elizabethwu1 on Fri, 11/22/2013 - 1:58pm NCT00934050 ELND005 United States Monday, June 1, 2009 – Wednesday, June 1, 2011 150 Phase 2 Alzheimer's Disease Friday, November 22, 2013 Elan Corporation Transition Therapeutics, Inc. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.